|
|
2579 Midpoint Drive
Fort Collins, CO 80525 USA
phone:604.707.7000
fax:604.707.7001
|
|
| Symbol |
QLT |
| Exchange |
NASDAQ |
| Founded |
0 |
| Employees |
|
|
|
| www.atrixlabs.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Specialty pharmaceutical company focused on advanced drug delivery. |
|
| Management |
| Robert Butchofsky, President and Chief Executive Officer; Alain Curaudeau, Senior Vice President, Portfolio and Project Management; Therese Hayes, Vice President, Investor Relations and Corporate Communications; Linda Lupini, Senior Vice President, Human Resources and Organizational Development; Alexander Lussow, Vice President, Business Development; Cameron Nelson, Vice President, Finance and Chief Financial Officer; Peter J. O'Callaghan, Senior Vice President, Corporate Development and General Counsel; Daniel Wattier, Vice President, Marketing and Sales |
| |
|
|
|
|
|
|
|
| Keywords |
| drug delivery, dermatology, pain management, oncology, PainManagement, DrugDelivery |
|
|
|
| Description |
|
Atrix Laboratories, Inc. is an emerging specialty pharmaceutical company focused on advanced drug delivery. Atrix has successfully applied its Atrigel drug formulation technology to introduce 1-month, 3-month 4-month formulations of Eligard, and in addition, is developing a 6-month formulation. |
|
| Products / Services |
The company's lead product is Eligard, a long-acting injectable formulation of leuprolide acetate for the treatment of prostate cancer that has been partnered in the US with Sanofi-Synthelabo.
Another near-term opportunity is Atrisone, a topical dermatology product (dapsone for acne) in late Phase III development that is being developed in collaboration with Fujisawa.
|
|
| Technology / Differentiation |
| With five unique patented technologies, Atrix is currently developing a diverse portfolio of proprietary products, including oncology, pain management and dermatology products.
The company also partners with large pharmaceutical and biotechnology companies to apply its proprietary technologies to new chemical entities or improve existing products |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
